Bursa Malaysia's Securities Trading unit is facing headwinds because of weak equity sentiment brought about by the ongoing ...

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

香港への重複上場に向けて、中国の車載電池大手、寧徳時代新能源科技（ＣＡＴＬ）が計画している新規株式公開（ＩＰＯ）は約４０億ドルと、今年これまでで世界最大規模になる見通しだが、米国本土の投資家は募集対象から除外されている。これによってＣＡＴＬは、さまざ ...

NEW YORK] Shein Group lowered US retail prices this week after the Trump administration temporarily cut duties on Chinese ...

Jiangsu Hengrui Pharmaceuticals is planning to raise as much as US$1.27 billion via an initial public offering in Hong Kong, joining a wave of Chinese companies seeking to tap the city's market.

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

And another scoop: Two of FTI Consulting’s top economics experts in Europe have left to join Jonathan Orszag’s upstart rival ...

Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday.

Pony.ai, which raised USD 413 million in a US IPO, is now planning a Hong Kong listing to fuel further expansion. The company operates 250 robotaxis and is developing mass production models with ...

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...